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Abstract
In 2009, for the first time in Cape Verde, an outbreak of dengue was reported and over
twenty thousand people were infected. Only a few prophylactic measures were taken. The
effects of vector control on disease spreading, such as insecticide (larvicide and adulticide)
and mechanical control, as well as an hypothetical vaccine, are estimated through simulations
with the Cape Verde data.
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1 Introduction
Dengue is a disease which is now endemic in Africa, America, Asia, and the Western Pacific. In
Europe there has been no registered cases so far, yet the main vector of the disease is already
present there and has been followed in Madeira. According to the World Health Organization
(www.who.int/topics/dengue/en, 2011), the incidence of dengue has grown drastically in the
last decades and roughly two fifths of the world population is now at risk. So far, the strategies
to control Aedes aegypti mosquito proved to be inefficient and the continuous level of surveillance
of the mosquito is low. Climatic changes, unsanitary habitat, poverty, uncontrolled urbanization,
and global travel favor the propagation of dengue fever. Inadequate water supply requires large-
scale water storages, which are ideal breeding habitats for mosquitoes. The increasing movement
of people and goods has enabled the dengue virus and its vectors to spread to new parts of the
world (Semenza and Menne, 2009). There is no effective vector control and dengue infection rates
have been increasing during the last 40 years, e.g., in Thailand has increased from 9/100,000 in
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1958 to 189/100,000 in 1998 (Healstead, 1992; Endy et al., 2002). The virus emerged for the first
time in Cape Verde at the end of September 2009. The outbreak was the biggest ever recorded
in Africa. As the population had never had contact with the virus, herd immunity was very low.
Dengue type 3 spread throughout four of the nine islands. The worst outbreak occurred on the
island of Santiago, where most people live, up to 1000 cases per day in November. The Ministry
of Health of Cape Verde reported over 20,000 cases of dengue fever, which is about 5% of the
total population of the country, between October and December 2009. From 173 cases of dengue
haemorrhagic fever reported, six people died (www.dengue.gov.cv, 2011; www.minsaude.gov.cv,
2011).
2 Dengue and Aedes aegypti
Dengue is transmitted to humans by mosquitoes, mainly Aedes aegypti, and exists either as dengue
fever (DF) or as dengue hemorrhagic fever (DHF). The disease can be contracted by one of four
types of viruses. Infection with one serotype confers lifetime immunity against that serotype, but
not to the others, and there is evidence that a prior infection increases the risk of developing
DHF for people infected with another serotype. DF is characterized by sudden high fever (3 to
7 days) without respiratory symptoms, intense headache, and painful joints and muscles. The
haemorrhagic form is also characterized by sudden fever, nausea, vomiting, and fainting due to
low blood pressure by fluid leakage. It usually lasts between two and three days and can lead to
death. There is no specific effective treatment for dengue. Fluid replacement therapy is used if
clinical diagnosis is made early. Vaccine candidates are undergoing clinical trials (www.who.int/
topics/dengue/en, 2011).
Aedes aegypti is closely associated with humans and their dwellings, thriving in crowded cities
and biting primarily during day light. Humans also provide nutrients needed for mosquitoes to
reproduce through water-holding containers, in and around human homes. In urban areas, Aedes
mosquitoes breed on water collections in artificial containers such as plastic cups, used tires,
broken bottles, and flower pots. With urbanization, crowded cities, poor sanitation, and lack of
hygiene, environmental conditions foster the spread of the disease which, even in the absence of
fatal forms, breeds significant economic and social costs (absenteeism, immobilization, debilitation,
and medication) (Derouich and Boutayeb, 2006; Ferreira et al., 2006).
Female mosquitoes acquire infection by taking a blood meal from an infected human. These
infected mosquitoes pass the disease to susceptible humans. Female mosquitoes lay their eggs on
inner wet walls of containers. Larvae hatch when water inundates eggs. In the following days,
the larvae feed on microorganisms and particulate organic matter. When the larva has acquired
enough energy and size, metamorphosis changes the larva into a pupa. Pupae do not feed: they
just change in form until the adult body, the fling mosquito, is formed. The newly formed adult
emerges from the water after breaking the pupal skin. The entire life cycle, from the aquatic phase
(eggs, larvae, pupae) to the adult phase, lasts from 8 to 10 days at room temperature, depending
on the level of feeding (Christophers, 2009).
It is very difficult to control or eliminate Aedes aegypti mosquitoes because they quickly adapt
to changes in the environment and they quickly pullulate again after droughts or prophylactic
measures. The transmission thresholds and the extent of dengue transmission are determined by
the level of herd immunity in the human population to circulating virus serotype(s), virulence char-
acteristics of the viral strain, survival, feeding behavior, abundance of Aedes aegypti, climate and
human density, distribution, and movement (Scott and Morrison, 2004). There are two primary
preventions: larval control and adult mosquito control, depending on the intended target (Natal,
2002). Larvicide treatment is an effective control of the vector larvae, together with mechanical
control, which is related to educational campaigns to remove still water from domestic recipients
and eliminating possible breeding sites. The larvicide should be long-lasting and preferably have
World Health Organization clearance for use in drinking water (Derouich et al., 2003). The ap-
plication of adulticides can drop the mosquito vector population. However, the efficacy is often
constrained by the difficulty in achieving sufficiently high coverage of resting surfaces (Devine
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et al., 2009).
While Feng and Velasco-Herna´ndez (1997) investigate the competitive exclusion principle in a
two-strain dengue model, Chowell et al. (2007) estimate the basic reproduction number for dengue
using spatial epidemic data. Tewa et al. (2009), established the global asymptotic stability of the
equilibria of a single-strain dengue model. Thome´ et al. (2010) introduce a sterile insect technique.
3 Model
We adapt the model presented in Dumont et al. (2008) and Dumont and Chiroleu (2010) to
dengue, with the considerations of Rodrigues et al. (2009, 2010a,b). We consider three controls
simultaneously: larvicide, adulticide, and mechanical control, with mutually-exclusive compart-
ments, to study the outbreak of 2009 in Cape Verde and improve upon Rodrigues et al. (2009).
We denote Sh the total number of susceptible, Ih the total number of infected and infectious,
and Rh the total number of resistant individuals. The total human population is a constant
Nh = Sh(t)+Ih(t)+Rh(t). The population is homogeneous, which means that every individual of
a compartment is homogeneously mixed with the other individuals. Immigration and emigration
are ignored.
Female mosquitoes are in total number Am in the aquatic phase (including egg, larva, and
pupa stages), Sm are susceptible, and Im are infected. Mosquitoes are considered to live too
briefly to develop resistance. Each mosquito has an equal probability to bite any host. Humans
and mosquitoes are assumed to be born susceptible.
We consider three controls: the proportion cA of larvicide, the proportion cm of adulticide, and
the proportion α of mechanical control. Larval control targets the immature mosquitoes living
in water before they bite. The natural soil bacterium Bacillus thuringiensis israelensis (Bti) is
sprayed from the ground or by air to larval habitats. The control of adult mosquitoes is necessary
when mosquito populations cannot be treated in their larval stage. Depending upon the size of
the area, either trucks for ground adulticide treatments or aircraft for aerial adulticide treatments
are used. The purpose of mechanical control is to reduce larval habitat areas. The parameters
used in the model are:
Nh total population;
B average daily biting (per day);
βmh transmission probability from Im (per bite);
βhm transmission probability from Ih (per bite);
1/µh average lifespan of humans (in days);
1/ηh mean viremic period (in days);
1/µm average lifespan of adult mosquitoes (in days);
ϕ number of eggs at each deposit per capita (per day);
1/µA natural mortality of larvae (per day);
ηA maturation rate from larvae to adult (per day);
m female mosquitoes per human;
k total number of larvae per human.
The dengue epidemic is modelled by the nonlinear time-varying state equations
S′h(t) = µhNh −
(
Bβmh
Im(t)
Nh
+ µh
)
Sh(t)
I ′h(t) = Bβmh
Im(t)
Nh
Sh(t)− (ηh + µh)Ih(t)
R′h(t) = ηhIh(t)− µhRh(t)
(1)
and 
A′m(t) = ϕ
(
1− Am(t)αkNh
)
(Sm(t) + Im(t))− (ηA + µA + cA)Am(t)
S′m(t) = ηAAm(t)−
(
Bβhm
Ih(t)
Nh
+ µm + cm
)
Sm(t)
I ′m(t) = Bβhm
Ih(t)
Nh
Sm(t)− (µm + cm) Im(t)
(2)
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Figure 1: Epidemiological model SIR (Susceptible, Infected, Recovered) + ASI (Aquatic phase,
Susceptible, Infected) with Sh, Ih, Rh, Am, Sm, and Im as state variables, cA, cm, and α as
controls, and Nh, B, βmh, βhm, µh, ηh, µm, ϕ, µA, ηA, m, and k as given parameters.
with the initial conditions
Sh(0) = Sh0, Ih(0) = Ih0, Rh(0) = Rh0,
Am(0) = Am0, Sm(0) = Sm0, Im(0) = Im0.
Figure 1 shows a scheme of the model.
4 Equilibrium points and the basic reproduction number
We study the solutions of System (1)–(2) in the closed set
Ω =
{
(Sh, Ih, Rh, Am, Sm, Im) ∈ R6+ : Sh + Ih +Rh ≤ Nh, Am ≤ kNh, Sm + Im ≤ mNh
}
.
The Ω set is positively invariant with respect to Eq. (1)–(2) (Rodrigues et al., 2012). System
(1)–(2) has at most three biologically meaningful equilibrium points (cf. Theorem 2).
Definition 1. A sextuple E = (Sh, Ih, Rh, Am, Sm, Im) ∈ R6 is an equilibrium point for System
(1)–(2) if it satisfies 
µhNh −
(
Bβmh
Im
Nh
+ µh
)
Sh = 0
Bβmh
Im
Nh
Sh − (ηh + µh)Ih = 0
ηhIh − µhRh = 0
ϕ
(
1− AmαkNh
)
(Sm + Im)− (ηA + µA + cA)Am = 0
ηAAm −
(
Bβhm
Ih
Nh
+ µm + cm
)
Sm = 0
Bβhm
Ih
Nh
Sm − (µm + cm)Im = 0.
(3)
An equilibrium point E is biologically meaningful if and only if E ∈ Ω. The biologically meaningful
equilibrium points are said to be disease-free or endemic depending on Ih and Im: if there is no
disease for both populations of humans and mosquitoes (Ih = Im = 0), then the equilibrium point
is a disease-free equilibrium (DFE); otherwise, if Ih > 0 or Im > 0, then the equilibrium point is
called endemic.
Theorem 2. System (1)–(2) admits at most three biologically meaningful equilibrium points, at
most two DFE points, and at most one endemic equilibrium point. Let
M = − (ηAµm + ηAcm + µAµm + µAcm + cAµm + cAcm − ϕηA) , (4)
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ξ = ϕ(µm + cm)
2(ηh + µh), χ = αkB
2βhmβmhM, (5)
E∗1 = (Nh, 0, 0, 0, 0, 0) , E
∗
2 =
(
Nh, 0, 0,
αkNhM
ηAϕ
,
αkNhM
(µm + cm)ϕ
, 0
)
, (6)
and E∗3 = (S
∗
h, I
∗
h, R
∗
h, A
∗
m, S
∗
m, I
∗
m) with
S∗h =
−ϕNh(µmηh + µhBβhm + cmµh + cmηh + µmµh)(µm + cm)
Bβhm(−αkBβmhM− ϕµh(µm + cm)) ,
I∗h =
µhNh (ξ − χ)
(ηh + µh)Bβhm(−αkBβmhM− ϕµh(µm + cm)) ,
R∗h =
ηhNh (ξ − χ)
(ηh + µh)Bβhm (−αkBβmhM− ϕµh(µm + cm)) ,
A∗m =
NhkαM
ϕηA
,
S∗m =
Nhµh(cm + µh)(µh + ηh)
Bβmh(µmηh + µhBβhm + c−mµh + cmηh + µmµh)
− Nhαk (cm(µh + ηh)(µA + ηA + cA) + µm(µh(ηA + µA) + ηh(cA + ηA)))
ϕ(µmηh + µhBβhm + c−mµh + cmηh + µmµh)
− Nhαk (−ηϕ(µh + ηh) + µm(ηhµA + µhcA))
ϕ(µmηh + µhBβhm + c−mµh + cmηh + µmµh) ,
I∗m =
−µhNh (ξ − χ)
Bβmh (ϕBβhmµh(µm + cm) + ξ)
.
(7)
If M ≤ 0, then there is only one biologically meaningful equilibrium point E∗1 , which is a DFE
point. If M > 0 with ξ ≥ χ, then there are two biologically meaningful equilibrium points E∗1
and E∗2 , both DFE points. If M > 0 with ξ < χ, then there are three biologically meaningful
equilibrium points E∗1 , E
∗
2 , and E
∗
3 , where E
∗
1 and E
∗
2 are DFEs and E
∗
3 is endemic.
Proof. System (3) has four solutions obtained with the software Maple: E∗1 , E
∗
2 , E
∗
3 , and E
∗
4 .
The equilibrium point E∗1 is always a DFE because it always belong to Ω with Ih = Im = 0. In
contrast, E∗4 is never biologically realistic because it always has some negative coordinates. The
other two equilibrium points, E∗2 and E
∗
3 , are biologically realistic only for certain values of the
parameters. The equilibrium E∗2 is biologically realistic if and only if M ≥ 0, in which case it is
a DFE. For the conditionM≤ 0, the third equilibrium E∗3 is not biologically realistic. IfM > 0,
then three situations can occur with respect to E∗3 : if ξ = χ, then E
∗
3 degenerates into E
∗
2 , which
means that E∗3 is the DFE E
∗
2 ; if ξ > χ, then E
∗
3 is not biologically realistic; otherwise, one has
E∗3 ∈ Ω with Ih 6= 0 and Im 6= 0, which means that E∗3 is an endemic equilibrium point.
By algebraic manipulation,M > 0 is equivalent to the condition (ηA + µA + cA)(µm + cm)
ϕηA
>
1, which is related to the number for offspring mosquitos. Thus, if M ≤ 0, then the mosquito
population will collapse and the only equilibrium for the whole system is the trivial DFE E∗1 . If
M > 0, then the mosquito population is sustainable. From a biological standpoint, the equilibrium
E∗2 is more plausible, because the mosquito is in its habitat, but without the disease.
Definition 3. (Hethcote, 2008) The basic reproduction number, denoted by R0, is defined as
the average number of secondary infections occurring when one infective is introduced into a
completely susceptible population.
The basic reproduction number provides an invasion criterion for the initial spread of the virus
in a susceptible population. For this case,
Theorem 4. The basic reproduction number R0 associated to the differential System (1)–(2) is
R0 =
(
αkB2βhmβmhM
ϕ(ηh + µh)(cm + µm)2
) 1
2
=
(
χ
ξ
) 1
2
. (8)
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Proof. In agreement with van den Driessche and Watmough (2002), we consider the epidemiolog-
ical compartments with new infections, Ih and Im. The two differential equations related with
these two compartments are rewritten as x′(t) = F(x(t))− V(x(t)), where x = (Ih, Im), F is the
rate of production of new infections, and V the transition rates between states:
F(x) =
(
Bβmh
Im
Nh
Sh
Bβhm
Ih
Nh
Sm
)
, V(x) =
(
(ηh + µh)Ih
(cm + µm)Im
)
.
The Jacobian derivatives are
JF(x) =
(
0 Bβmh
Sh
Nh
Bβhm
Sm
Nh
0
)
, JV(x) =
(
ηh + µh 0
0 cm + µm
)
.
The quantity JF(x)J
−1
V(x) gives the total number of new infections over the course of an outbreak.
The largest eigenvalue gives the asymptotic growth of the infected population, giving R0 as the
spectral radius of the matrix JF(x)J
−1
V(x) in a DFE point. Maple was used to obtain
R0 =
(
B2βhmβmhShDFESmDFE
(ηh + µh)(cm + µm)N2h
) 1
2
. (9)
The basic reproduction number R0 in Eq. (8) is obtained from replacing ShDFE and SmDFE in
Eq. (9) by those of the DFE E∗2 .
The model plays on the populations of host and vector, and the expected basic reproduction
number should reflect the infection transmitted from host to vector and vice-versa. Accordingly,
R0 can be seen as R0 = (Rhm × Rmh) 12 . The infection host-vector is represented by Rhm =
BβhmSmDFE
Nh(ηh+µh)
, where the term
BβhmSmDFE
Nh
represents the transmission probability of the disease
from humans to mosquitoes in a susceptible population of vectors, and the term 1ηh+µh the human
viremic period. Analogously, the infection vector-host is represented by Rmh = BβmhShDFENh(cm+µm) , where
BβmhShDFE
Nh
represents the transmission of the disease from mosquito to the susceptible human
population, and 1cm+µm the lifespan of an adult mosquito.
If R0 < 1, on average, an infected individual produces less than one new infected individual
over the course of its infectious period, and the disease declines. Conversely, if R0 > 1, then each
individual infects more than one person, and the disease invades the population.
Theorem 5. If M > 0 and R0 > 1, then System (1)–(2) admits the endemic equilibrium E∗3 =
(S∗h, I
∗
h, R
∗
h, A
∗
m, S
∗
m, I
∗
m) given by Eq. (7).
Proof. The only solution of Eq. (3) with Ih > 0 or Im > 0, the only endemic equilibrium, is E
∗
3 .
That occurs, in agreement with Theorem 2, in the case M > 0 and χ > ξ. The condition χ > ξ
is equivalent, by Theorem 4, to R0 > 1.
Using the methods developed in Li and Muldowney (1996) and van den Driessche and Wat-
mough (2002), ifR0 ≤ 1, then the DFE is globally asymptotically stable in Ω, and the vector-borne
disease always dies out; if R0 > 1, then the unique endemic equilibrium is globally asymptotically
stable in Ω, so that the disease, if initially present, persists at the unique endemic equilibrium
level.
5 Numerical implementation
In the epidemic of Cape Verde, infections were rising at a rate of one thousand people a day.
The entire population was asked to participate in the campaign of cleaning and eradication of the
mosquito, with the help of the police and the army. Data for humans are available at www.ine.cv
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(a) Human population in the compartments Susceptible (Sh), Infected (Ih), and Recovered (Rh).
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(b) Mosquito population in the compartments Aquatic phase (Am), Susceptible (Sm), and Infected (Im).
Figure 2: Variation of human and mosquito populations when no control is applied, i.e., for System
(1)–(2) with cA = 0, cm = 0, and α = 1.
(2011), but knowledge of mosquitoes in Africa is poor. For Aedes aegypti, Esteva and Yang (2005)
and Coelho et al. (2008) have collected observations from Brazil. The simulations were carried
out with Nh = 480, 000, B = 0.8, βmh = 0.375, βhm = 0.375, µh = 1/(71 × 365), ηh = 1/3,
µm = 1/10, µm = 1/10, ϕ = 6, µA = 1/4, ηA = 0.08, m = 3, k = 3. The initial conditions for the
problem are: Sh0 = Nh − 10, Ih0 = 10, Rh0 = 0, Am0 = kNh, Sm0 = mNh, Im0 = 0. With these
values, Eq. (4) gives M > 0. The time interval is one year and tf = 365 days. We performed all
simulations and graphics with Matlab. To solve System (1)–(2), we used the ode45 routine. This
function implements a Runge–Kutta method with a variable time step for efficient computation.
Figures 2a and 2b show the human and mosquito populations in the absence of any control.
The human infection reached a peak between the 30th and the 50th day. The infection of the
mosquitoes is delayed. The total number of infected humans obtained from System (1)–(2) is
higher than observations in Cape Verde. The difference can be due to our inability to quantify
individual prophylactic efforts.
Figures 3a and 3b on adulticide control, Figures 4a and 4b on larvicide control, and Figures 5a
and 5b on mechanical control show that a small quantity of each control is efficient to drop
infection. Figures 3a and 3b show that the human population is already well protected by covering
only 25% of the country with insecticide for adult mosquitoes. However, we consider that Aedes
7
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(a) Variation of infected individuals (Ih) with adulticide.
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(b) Variation of infected mosquitoes (Im) with adulticide.
Figure 3: Variation of infected human and infected mosquito populations with different levels of
adulticide: cm = 0, cm = 0.25, cm = 0.50, cm = 0.75, and cm = 1. The other controls are not
applied: cA = 0, and α = 1.
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(a) Variation of infected individuals (Ih) with larvicide.
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(b) Variation of infected mosquitoes (Im) with larvicide.
Figure 4: Variation of infected human and infected mosquito populations with different levels of
larvicide: cA = 0, cA = 0.25, cA = 0.50, cA = 0.75, and cA = 1. The other controls are not
applied: cm = 0, and α = 1.
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(a) Variation of infected individuals (Ih) with mechanical control.
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(b) Variation of infected mosquitoes (Im) with mechanical control.
Figure 5: Variation of infected human and infected mosquito populations with different levels of
mechanical control: α = 0.01, α = 0.25, α = 0.5, α = 0.75, and α = 1. The other controls are not
applied: cm = 0, and cA = 0.
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(a) Variation of infected individuals (Ih) with a combined use of the three controls.
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(b) Variation of infected mosquitoes (Im) with a combined use of the three controls.
Figure 6: Variation of infected human and infected mosquito populations when using larvicide,
adulticide, and mechanical control simultaneously: cA = cm = 1− α = 0, 0.01, 0.05, 0.1, 0.15.
aegypti does not become resistant to insecticide and that there is no shortage of insecticide.
Figures 4a, 4b, 5a, and 5b show the controls applied in the aquatic phase of the mosquito. The
controls were studied separately, but each one is closely related to the other. None of these controls
is sufficient to drop the total number of infected humans to zero, but the removal of breeding sites
and the use of larvicide contributes to prophylaxis.
Figures 6a and 6b show simulations using the three controls simultaneously. They show that
10% of each control, applied continuously, is enough to contain the infection near zero case.
The eradication of Aedes aegypti may not be feasible and, from the environment point of view,
not desirable. The aim is to reduce the mosquito density and increase the immunity on the humans.
Population herd immunity can be reached by increasing the total number of resistant persons to
the disease, which implies that these persons have been infected, or through vaccination.
No commercially available clinical cure or vaccine is currently available for dengue, but efforts
are to develop one (Blaney et al., 2007; Hombach et al., 2007). Effective vaccines have been pro-
duced against other flavivirus diseases such as yellow fever, Japanese encephalitis, and tick-borne
encephalitis, so there is good hope for a vaccine for dengue. We now simulate the epidemiological
model with vaccination.
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Figure 7: Epidemiological SVIR (Susceptible, Vaccinated, Infected, Recovered) model for humans
with Sh, Vh (human vaccinated population), Ih, and Rh as state variables, p (proportion of the
vaccinated new born) as the control, and Nh, B, βmh, µh, ηh, w (proportional rate at which vacci-
nation loses effect), Ψ (fraction of the vaccinated susceptible), and σ (infection rate of vaccinated
people) as given parameters.
6 Model with vaccination
While direct individual protection is the major focus of mass vaccination program, population
effects also contribute to individual protection through herd immunity, providing protection for
unprotected individuals (Farrington, 2003). The more vaccinated people, the less likely a suscep-
tible person will come into contact with the infection. With the introduction of a vaccine, the SIR
model related to the human population is augmented into the SVIR model of Figure 7, where Vh
represents the total number of vaccinated people.
Vaccination is continuous with a constant proportion p of vaccinated new born. A fraction Ψ
of the susceptible is vaccinated. The vaccination reduces but does not eliminate susceptibility to
infection. For this reason we consider the infection rate σ of vaccinated people: when σ = 0 the
vaccine is perfect and when σ = 1 the vaccine has no effect at all. The vaccination loses efficacy
at a rate w. The differential system for the host population is:
S′h(t) = (1− p)µhNh + wVh(t)−
(
Bβmh
Im(t)
Nh
+ Ψ + µh
)
Sh(t)
V ′h(t) = pµhNh + ΨSh(t)−
(
w + σBβmh
Im(t)
Nh
+ µh
)
Vh(t)
I ′h(t) = Bβmh
Im(t)
Nh
(Sh(t) + σVh(t))− (ηh + µh)Ih(t)
R′h(t) = ηhIh(t)− µhRh(t).
Figure 8 shows simulations for decreasing vaccine efficacy. Larvicide, insecticide, and mechan-
ical control were kept null, and the parameters σ and w were changed. For 80% of the population
vaccinated, the efficacy of the vaccine reduces the disease spread.
Figure 9 presents the proportion of population vaccinated. It shows that dengue fever prophy-
laxis articulates health and sustainable development.
7 Conclusion
Our simulations, based on our compartmental epidemiological model and formalizing clean-up
campaigns to remove the vector breeding sites and the application of insecticides (larvicide and
adulticide), have shown that even with a low continuous control over time, the results are encour-
aging. The model with an imperfect vaccine has shown that the total number of infected persons
can decrease quickly.
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Figure 8: Total number of infected humans for decreasing vaccine efficacy (σ = 1− w = 0, 0.25,
0.5, 0.75, 1), p = 0.80, and Ψ = 0.80.
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Figure 9: Total number of infected humans when using different values of population vaccinated
(Ψ = 0, 0.25, 0.5, 0.75, 1), p = 0, w = 0.85, and σ = 0.15.
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